Todea Ramona-Alexandra, Lu Po-Jui, Fartaria Mario Joao, Bonnier Guillaume, Du Pasquier Renaud, Krueger Gunnar, Bach Cuadra Meritxell, Psychogios Marios Nikos, Kappos Ludwig, Kuhle Jens, Granziera Cristina
Translational Imaging in Neurology (ThINk) Basel, Department of Biomedical Engineering, Basel University Hospital, University of Basel, Basel, Switzerland.
Section of Neuroradiology, Department of Radiology, University Hospital of Basel, Basel, Switzerland.
Front Neurol. 2020 Sep 4;11:973. doi: 10.3389/fneur.2020.00973. eCollection 2020.
Changes in cortical and white matter lesion (CL, WML) load are pivotal metrics to diagnose and monitor multiple sclerosis patients. Yet, the relationship between (i) changes in CL/WML load and disease progression and between (ii) changes in CL/WML load and neurodegeneration at early MS stages is not yet established. In this work, we have assessed the hypothesis that the combined CL and WML load as well as their 2-years evolution are surrogate markers of neurodegeneration and clinical progression at early MS stages. To achieve this goal, we have studied a group of RRMS patients and have investigated the impact of both CL and WML load on neuroaxonal damage as measured by serum neurofilament light chain (sNfL). Next, we have explored whether changes in CL/WML load over 2 years in the same cohort of early-MS are related to motor and cognitive changes. Thirty-two RRMS patients (<5 years disease duration) underwent: (i) 3T MRI for CL/WML detection and clinical assessment at baseline and 2-years follow-up; and (ii) baseline blood test for sNfL. The correlation between the number and volume of CL/WML and sNfL was assessed by using the Spearman's rank correlation coefficient and a generalized linear model (GLM). A GLM was also used to assess the relationship between (i) the number/volume of new, enlarged, resolved, shrunken, stable lesions and (ii) the difference in clinical scores between two time-points. At baseline, sNfL levels correlated with both total CL count/volume (ρ = 0.6/0.7, Corr- <0.017/Corr- < 0.001) and with total WML count/volume (ρ = 0.6/0.6, Corr- < 0.01 for both). Baseline sNfL levels also correlated with new WML count/volume (ρ = 0.6/0.5, Corr-P < 0.01/Corr-P < 0.05) but not with new CL. Longitudinal changes in CL and WML count and volume were significantly associated with (i) sustained attention, auditory information, processing speed and flexibility ( < 0.01), (ii) verbal memory ( < 0.01); (iii) verbal fluency ( < 0.05); and (iv) hand-motor function ( < 0.05). : Changes in cortical and white matter focal damage in early MS patients correlate with global neuroaxonal damage and is associated to cognitive performances.
皮质和白质病变(CL,WML)负荷的变化是诊断和监测多发性硬化症患者的关键指标。然而,(i)CL/WML负荷变化与疾病进展之间以及(ii)早期MS阶段CL/WML负荷变化与神经退行性变之间的关系尚未明确。在这项研究中,我们评估了以下假设:CL和WML负荷的总和及其2年的变化是早期MS阶段神经退行性变和临床进展的替代标志物。为实现这一目标,我们研究了一组复发缓解型多发性硬化症(RRMS)患者,并研究了CL和WML负荷对血清神经丝轻链(sNfL)测量的神经轴突损伤的影响。接下来,我们探讨了同一组早期MS患者中2年内CL/WML负荷的变化是否与运动和认知变化相关。32例RRMS患者(病程<5年)接受了:(i)在基线和2年随访时进行3T MRI以检测CL/WML并进行临床评估;(ii)在基线时进行sNfL血液检测。使用Spearman等级相关系数和广义线性模型(GLM)评估CL/WML的数量和体积与sNfL之间的相关性。GLM还用于评估(i)新出现、扩大、消退、缩小、稳定病变的数量/体积与(ii)两个时间点之间临床评分差异之间的关系。在基线时,sNfL水平与CL总数/体积(ρ = 0.6/0.7,相关系数<0.017/相关系数<0.001)以及WML总数/体积(ρ = 0.6/0.6,两者相关系数<0.01)均相关。基线sNfL水平也与新出现的WML数量/体积(ρ = 0.6/0.5,相关系数P<0.01/相关系数P<0.05)相关,但与新出现的CL无关。CL和WML数量及体积的纵向变化与(i)持续注意力、听觉信息、处理速度和灵活性(<0.01)、(ii)言语记忆(<0.01)、(iii)言语流畅性(<0.05)以及(iv)手部运动功能(<0.05)显著相关。早期MS患者皮质和白质局灶性损伤的变化与整体神经轴突损伤相关,并与认知表现有关。